ZKR Orthopedics receives FDA breakthrough device designation for LIFT implant
Click Here to Manage Email Alerts
Key takeaways:
- ZKR Orthopedics has announced FDA breakthrough device designation of its LIFT implant technology.
- The LIFT implant is designed to unload the patellofemoral compartment for patients with osteoarthritis and pain.
ZKR Orthopedics Inc. has announced FDA breakthrough device designation of its LIFT implant for patients with late-stage cartilage degeneration and patellofemoral osteoarthritis, according to a press release.
The LIFT implant is designed to elevate and realign the patella tendon by decreasing the compressive forces that cause knee pain and inhibit knee function. According to the release, the system is for patients looking to delay or eliminate the need for total knee replacement.
“We much appreciate the breakthrough device designation from the FDA,” David Cash, CEO of ZKR Orthopedics, said in the release. “The accelerated regulatory review will likely shorten the time to market allowing expanded options for patients suffering from patellofemoral osteoarthritis. Our hope is to improve both pain and function before the onset of comorbidities associated with a sedentary lifestyle,” Cash said.
Read more about
Click Here to Manage Email Alerts